An 82-year-old Japanese man was referred for detailed examination of hyperkeratotic erythematous plaques on his palms and soles for 6 months. Two weeks before his first visit, he had undergone lung lobectomy for right lung squamous cell carcinoma (SCC). Laboratory findings showed elevations of eosinophil counts, serum IgE, thymus and activation-regulated chemokine, SCC antigen, and soluble interleukin-2 receptor levels. Histological results of a skin biopsy involving the left palm showed psoriasiform dermatitis. Before lung lobectomy, the hyperkeratotic erythematous plaques on the palms and soles and the erythemas on the trunk and extremities were difficult to treat with topical steroids. After lobectomy, the skin symptoms dramatically and rapidly subsided with topical steroids. Therefore, we diagnosed Bazex syndrome (BS), also known as acrokeratosis paraneoplastica, as a paraneoplastic cutaneous disease in lung SCC. The mild eosinophilia subsided and levels of SCC antigen, IgE, and soluble interleukin-2 receptor were reduced. BS is a paraneoplastic cutaneous disease characterized by acral psoriasiform lesions associated with an underlying neoplasm. In a previous report, a shift to the Th2 immune condition was found in patients with non-small cell lung cancer, as shown in our patient. Epidermal growth factor receptor (EGFR) is also known as tumor growth factor-α receptor; it is increased in psoriatic keratinocytes. In our case, EGFR expression increased in lesional keratinocytes 2 weeks after surgery and decreased 4 weeks after surgery. We speculate that a shift to Th2 immune reactions in lung SCC may be the pathogenesis of BS, whereby lesional keratinocytes highly express EGFR in parallel with disease activity.

An 82-year-old Japanese man was referred for detailed examination of hyperkeratotic erythematous plaques on his hands (palms) and feet (soles) for 6 months. Two weeks before his first visit, he had undergone lung lobectomy for right lung squamous cell carcinoma (SCC). He had a history of tongue and gastric cancer, both of which were in remission. On admission, he had hyperkeratotic erythematous plaques on his palms and soles (Fig 1). Multiple itchy, coalescing, scaly, papular erythemas, 20 mm in diameter, were on his trunk and extremities but did not cover more than 90% of his entire body surface area, which is the definition of erythroderma. Transverse abdominal folds were not spared, indicating that the “deck chair” sign characteristic of papuloerythroderma of Ofuji was negative. Laboratory findings were as follows: white blood cell count, 9.4 × 103/μL (normal range, 3.6–9.3 × 103/L); eosinophils, 9.4%, 8.3 × 102/μL (normal range, 0.6–8.0%); hemoglobin, 12.6 g/dL (normal range, 13.8–16.9 g/dL); C-reactive protein, 0.11 mg/L (normal range, 0.0–0.2 mg/L); creatinine, 0.74 mg/dL (normal range, 0.7–1.1 mg/dL); alanine aminotransferase, 17 U/L (normal range, 8–48 U/L); IgE, 4,686 IU/mL (normal level, <295 IU/mL); thymus and activation-regulated chemokine (TARC), 3,984 pg/mL (normal level, 450 pg/mL); SCC antigen, 15.4 ng/mL (normal level, <1.5 ng/mL); and soluble interleukin-2 receptor, 1,050 U/mL (normal range, 145–519 U/mL). His Brinkman index score was 1,600 and he stopped smoking after the diagnosis of lung cancer. Histological results of a skin biopsy involving the left palm revealed parakeratosis, acanthosis, elongated rete ridges, and perivascular lymphocyte infiltration in the upper dermis. The granular layer remained and exocytosis of lymphocytes was found (Fig 2a, b). Biopsy involving erythema of the left forearm revealed an eczematous reaction. Contrast-enhanced computed tomography did not detect additional internal malignancies. Before lung lobectomy, the hyperkeratotic erythematous plaques on the palms and soles and the erythemas on the trunk and extremities were difficult to treat with topical steroids. After lobectomy, the skin symptoms dramatically and rapidly subsided with topical steroids. There was no history of palmoplantar keratosis. Potassium hydroxide preparation and microscopic examination of the soles did not reveal any tinea infection. No drugs were suspected of causing adverse cutaneous reactions. Therefore, we diagnosed Bazex syndrome (BS), also known as acrokeratosis paraneoplastica, as a paraneoplastic cutaneous disease in lung SCC. Mild eosinophilia and elevated SCC antigen, IgE, and soluble interleukin-2 receptor levels improved to 8.9% (4.8 × 102/μL), 13.2 ng/mL, 1,957 U/mL, and 486 U/mL, respectively; however, elevated serum TARC levels remained as high as 4,277 pg/mL 6 months after lung lobectomy.

Fig. 1.

Clinical appearance during the first visit. Hyperkeratotic erythematous plaque on the left sole. Hyperkeratotic erythematous plaques developed on the bilateral palms and soles. Nails were thickened and fissures were found. Examination using potassium hydroxide on the scales was negative for a fungal infection.

Fig. 1.

Clinical appearance during the first visit. Hyperkeratotic erythematous plaque on the left sole. Hyperkeratotic erythematous plaques developed on the bilateral palms and soles. Nails were thickened and fissures were found. Examination using potassium hydroxide on the scales was negative for a fungal infection.

Close modal
Fig. 2.

Histological and immunohistochemical findings during the first visit. a, b Skin biopsy of hyperkeratotic erythema on the left palm. Hematoxylin and eosin staining revealed parakeratosis, acanthosis, elongated rete ridges, and perivascular lymphocyte infiltration of the upper dermis. The granular layer did not disappear and exocytosis of lymphocytes was found. Original magnifications: ×40 (a) and ×100 (b). c, d Immunohistochemical staining with EGFR of hyperkeratotic erythema on the left palm 2 weeks (c) and on the left sole 4 weeks (d) after lobectomy for lung cancer. Lesional keratinocytes highly expressed EGFR 2 weeks after surgery, and its expression was decreased 4 weeks after surgery. Original magnifications: ×100 (c) and ×100 (d).

Fig. 2.

Histological and immunohistochemical findings during the first visit. a, b Skin biopsy of hyperkeratotic erythema on the left palm. Hematoxylin and eosin staining revealed parakeratosis, acanthosis, elongated rete ridges, and perivascular lymphocyte infiltration of the upper dermis. The granular layer did not disappear and exocytosis of lymphocytes was found. Original magnifications: ×40 (a) and ×100 (b). c, d Immunohistochemical staining with EGFR of hyperkeratotic erythema on the left palm 2 weeks (c) and on the left sole 4 weeks (d) after lobectomy for lung cancer. Lesional keratinocytes highly expressed EGFR 2 weeks after surgery, and its expression was decreased 4 weeks after surgery. Original magnifications: ×100 (c) and ×100 (d).

Close modal

BS is a paraneoplastic cutaneous disease characterized by acral psoriasiform lesions associated with an underlying neoplasm. The skin of the palms and soles initially thickens when the neoplasm is not active. Subsequently, the trunk and extremities become involved, as shown in our patient [1, 2]. The pathogenesis of BS is unknown, but some immunological mechanisms are hypothesized and serum levels of SCC antigen can parallel the severity of cutaneous lesions [3]; however, they can also parallel the severity of the primary malignancy as a tumor marker. In a previous report, a shift to the Th2 immune condition was found in patients with non-small cell lung cancer. Radical surgery treatment may improve the Th1/Th2 shift in patients [4], as shown in our patient, who had an eczematous reaction on the extremities and trunk with the increased serum IgE and TARC and increased eosinophil count. Serum IgE level and eosinophil count were decreased after surgery. Cigarette smoking increases some inflammation markers, including TARC [5]. Epidermal growth factor receptor (EGFR) is also known as tumor growth factor-α receptor; it is increased in psoriatic keratinocytes [6] and decreased in atopic dermatitis (AD) keratinocytes [7]. We compared the expression of EGFR in lesional keratinocytes between 2 and 4 weeks after lobectomy. Surprisingly, its expression was increased in lesional keratinocytes of the left palm 2 weeks after surgery and decreased in those of the left sole 4 weeks after surgery (Fig 2c, d). From these results, we speculate that a shift to Th2 immune reactions in lung SCC, which is similar to that in AD patients, may be the pathogenesis of acral psoriasiform lesions in BS, whereby lesional keratinocytes highly express EGFR in parallel with disease activity; however, it is usually suppressed in AD patients.

The authors have no ethical conflicts to disclose.

The authors have no conflicts of interest to disclose.

1.
Bazex A, Griffiths A: Acrokeratosis paraneoplastica – a new cutaneous marker of malignancy. Br J Dermatol 1980;103: 301–306.
2.
Valdivielso M, Longo I, Suarez R, Huerta M, Lazaro P: Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol 2005;19: 340–344.
3.
Hara M, Hunayama M, Aiba S, Suetake T, Watanabe M, Tanaka M, Tagami H: Acrokeratosis paraneoplastica (Bazex syndrome) associated with primary cutaneous squamous cell carcinoma of the lower leg, vitiligo and alopecia areata. Br J Dermatol 1995;133: 121–124.
4.
Li J, Wang Z, Mao K, Guo X: Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer. Oncol Lett 2014;8: 1682–1686.
5.
Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK: Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst 2014;106:dju294.
6.
Krueger JG, Krane JF, Carter DM, Gottlieb AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990;94: 135S–140S.
7.
Saaf A, Pivarcsi A, Winge MC, Wahlgren CF, Homey B, Nordenskjold M, Tengvall-Linder M, Bradley M: Characterization of EGFR and ErbB2 expression in atopic dermatitis patients. Arch Dermatol Res 2012; 304: 773–780.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.